Aquis Exchange Delivers Profit as the AQSE Exchange gathers Momentum
(AQX unaudited results for the six months ended 30 June 2021 reflected a strong period of revenue and profit growth with the Company reporting almost £14m of cash and equivalents on the balance sheet.
The Company successfully implemented numerous planned enhancements for the AQSE market during the period, which was clearly well received by the market with 14 admissions to the exchange reported for the period compared to three during 1H20.
AQSE Issuer revenue therefore increased to £0.34m as the number of admissions on AQSE grew year on year.
All new admissions were well supported in the aftermarket with the Company declaring a strong pipeline of high growth and 'new economy' businesses in conversation with AQSE regarding IPO into 2H21.
The Company also entered into strategic arrangements with Fregnan Ltd and Research Tree Ltd. to produce and publish research on AQSE's top-tier Apex stocks, ensuring every Apex stock now has quantitative research published on it, provided by Fregnan.
Alasdair Haynes, Chief Executive Officer of Aquis, commented: "We are delighted to announce that profits have continued to increase, reflecting the strong momentum maintained in revenue growth.
Following the completion of the acquisition of AQSE in March 2020, we introduced a number of strategic initiatives which have significantly improved liquidity, spreads and the overall attractiveness of the market. These changes have had a material effect on the number of companies admitted to trading with 14 new admissions during the first half, compared to three in 1H20.
View from Vox
AQSE is a clearly becoming a disruptive technology provider to the European trading markets, bringing positive increased competition to the listed SME sector.
As one of the only two options currently available to fast growing SMEs looking to IPO in the UK, AQSE is rapidly becoming a standout contender as the GoTo destination for quality growth businesses.
Shares in Aquis have almost doubled over the past 12 months with the shares trading between 605p and 720p over the past three months with analysts at Liberum targeting 850p for the Company.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.